Range Low Price High Price Comment
30 days $27.00 $36.72 Wednesday, 27th Mar 2024 ARWR stock ended at $28.70. This is 3.09% more than the trading day before Tuesday, 26th Mar 2024. During the day the stock fluctuated 3.63% from a day low at $27.86 to a day high of $28.87.
90 days $27.00 $39.83
52 weeks $20.67 $42.48

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
2023-06-08 $36.38 $36.78 $35.57 $35.70 584 155
2023-06-07 $36.19 $36.74 $35.38 $36.46 671 791
2023-06-06 $35.14 $36.34 $34.95 $36.12 619 425
2023-06-05 $35.49 $36.16 $34.97 $35.00 709 514
2023-06-02 $35.49 $36.07 $34.56 $36.05 942 367
2023-06-01 $34.55 $35.20 $33.25 $34.67 1 021 148
2023-05-31 $32.98 $34.91 $32.91 $34.41 1 793 500
2023-05-30 $33.50 $34.38 $32.30 $32.78 711 894
2023-05-26 $33.50 $33.89 $32.97 $33.60 781 754
2023-05-25 $35.51 $35.51 $33.15 $33.57 989 856
2023-05-24 $35.96 $36.06 $35.21 $35.57 868 913
2023-05-23 $36.65 $38.55 $36.27 $36.28 880 425
2023-05-22 $36.37 $37.10 $36.31 $36.52 613 280
2023-05-19 $36.95 $37.18 $36.18 $36.27 636 417
2023-05-18 $36.97 $36.97 $35.49 $36.28 908 042
2023-05-17 $37.82 $37.82 $36.71 $37.10 929 626
2023-05-16 $39.36 $39.36 $37.41 $37.64 973 055
2023-05-15 $39.37 $40.89 $39.02 $39.89 905 903
2023-05-12 $39.05 $39.44 $38.05 $39.32 981 754
2023-05-11 $40.45 $40.54 $39.50 $40.08 639 575
2023-05-10 $41.28 $41.28 $39.46 $40.49 694 167
2023-05-09 $39.97 $41.00 $39.23 $40.47 638 895
2023-05-08 $41.33 $41.36 $39.57 $40.45 770 162
2023-05-05 $40.70 $42.48 $40.48 $41.38 1 311 181
2023-05-04 $40.22 $40.46 $38.45 $40.05 1 502 634
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT